August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
July 31, 2015 — Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are on the hunt for biomarkers ...
June 29, 2015 - The Global Nuclear Medicine Diagnostics Market report from Mordor Intelligence revealed that North ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
June 12, 2015 - A first-in-human study shows how a powerful new drug finds and attaches itself to the ovarian and ...
June 12, 2015 - Neuroinflammation caused by a reactive immune system could be tripping off the neurodegeneration seen in ...
June 12, 2015 - Siemens' PETNET Solutions Inc. has entered into a nationwide agreement with U.K.-based Blue Earth ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
June 12, 2015 - A new molecular imaging agent has been demonstrated to find prostate cancer that has spread to other ...
June 11, 2015 - At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 ...
June 8, 2015 - GE Healthcare announced that it has created a solution to make positron emission tomography (PET) tracers ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
May 27, 2015 — Ipsen announced the signature of an agreement to acquire OctreoPharm Sciences, a private German life ...
May 13, 2015 — Cancer Targeted Technology (CTT), announced that it was awarded a NIH two-year, $2 million Small Business ...
<p>Nuclear myocardial perfusion imaging (MPI) with positron emission tomography (PET) and single-photon emission ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the ...
January 30, 2015 — The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based ...
January 13, 2015 — Scientists at the Riken Center for Life Science Technologies, along with researchers from the AIST ...
January 8, 2015 — Research and Markets has announced the addition of the "MediPoint: Nuclear Imaging - PET and SPECT ...
A study from Massachusetts General Hospital (MGH) investigators has identified for the first time changes in the ...
September 25, 2014 — A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing ...
August 27, 2014 — Telik Inc., a clinical stage oncology drug development company that merged with MabVax Therapeutics ...
August 5, 2014 — GE Healthcare announced its first integrated, simultaneous, time-of-flight (TOF) capable, whole-body ...
August 21, 2015 